HEALEY ALS PLATFORM TRIAL CLINICAL RESEARCH SUPPORT AGREEMENTClinical Research Support Agreement • October 19th, 2020 • Tottenham Acquisition I LTD • Blank checks • Massachusetts
THIS CLINICAL RESEARCH SUPPORT AGREEMENT (“Agreement”) is made and entered into as of September 27, 2019 (“Effective Date”) by and between Clene Nanomedicine, Inc. (“Company”) a Delaware corporation, duly organized under law, and having an address at 3165 E. Millrock Drive, Suite 325, Salt Lake City, UT 84121 and The General Hospital Corporation d/b/a Massachusetts General Hospital (“MGH”), a not-for-profit corporation organized under the laws of Massachusetts with its principal place of business at 55 Fruit Street, Boston, MA 02114. MGH and Company are each a (“Party”) to the Agreement and are collectively, the (“Parties”).
INVESTIGATOR-INITIATED CLINICAL RESEARCH SUPPORT AGREEMENTClinical Research Support Agreement • January 22nd, 2021 • Lixte Biotechnology Holdings, Inc. • Pharmaceutical preparations • California
This Investigator-Initiated Clinical Research Support Agreement (this “Agreement”) is made as of January 13, 2021 (“Effective Date”) by and between City of Hope National Medical Center and City of Hope Medical Foundation (collectively, “Institution”), and Lixte Biotechnology Holdings, Inc., a Delaware corporation (“Corporation”). The Institution and Corporation are each referred to herein as a “Party”, and collectively, as the “Parties”.
